L 30, C o llin s Pla ce , 35 C o llin s S t r e e t , M e lb o u r n e , VIC 3000, Au s t r a liaE:in fo @ Pe r ch e r o n T x . co m ¦ T:+61 3 9827 8999www.PercheronTx.com 8 September 2026 ASX Market Announcements O?ice ASX Limited Level 4, North Tower, Rialto Building 525...
Notice under S708A
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Application for quotation of securities - PER
- 2026 Notice of Annual General Meeting
- Percheron Therapeutics Limited Corporate Presentation
- Percheron raises $2.3m to fully fund clinical trial in AML
- Proposed issue of securities - PER
Later from Percheron Therapeutics
- Dr Michael Baker Commences as CEO and MD
- Initial Director's Interest Notice
- Final Director's Interest Notice
- Annual General Meeting - Chair Address
- Annual General Meeting - Management Presentation
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics